Pharmafile Logo
Pharmafocus logo
Advanced Search

HIV

Showing 15 posts of 200 posts found.

Gilead’s pill shows promise in HIV prevention

November 25, 2010
Research and Development, Sales and Marketing AIDS, Bill and Melinda Gates Foundation, Gilead, HIV, UN, UNAIDS, emtricitabine, tenofovir

Gilead’s HIV drug Truvada can help prevent men from contracting the disease through sexual intercourse, a new study shows.The clinical …

News

UN says Treatment 2.0 approach needed for AIDS

November 25, 2010
Research and Development, Sales and Marketing AIDS, HIV, UN, UNAIDS

A new report on the spread of AIDS has called for the development of new pharma compounds that will lead …

News

FDA approves Merck’s HIV fat drug Egrifta

November 12, 2010
Research and Development, Sales and Marketing EMD Serono, Egrifta, FDA, HIV, Merck KGaA, abdominal fat in HIV, tesamorelin

US regulatory authorities have approved the first treatment indicated to target abdominal fat in patients with HIV after trials showed …

News

Pepscan and Tibotec sign peptides deal

September 15, 2010
Research and Development, Sales and Marketing CLIPS, HIV, J&J, JJ, Pepscan, Tibotec

Pepscan Therapeutics, the biotech firm focusing on protein mimicry technology has signed a deal with Tibotec. Netherlands-based Pepscan will use …

News

BMS factory closure could interrupt HIV drug supply

June 11, 2010
Manufacturing and Production BMS, HIV, manufacturing, supply chain

Closure of a manufacturing facility in France operated by Bristol-Myers Squibb could lead to shortages of an important treatment for …

News

Merck’s HIV treatment fails in phase III

February 18, 2010
Research and Development HIV, Merck

Merck’s HIV treatment vicriviroc has disappointed in phase III trials, and may be dropped by the company. The results failed …

News

New market access approach could save poorer countries millions

December 1, 2009
Sales and Marketing HIV, access, developing world

  An innovative approach to improving access to drugs for HIV/Aids, tuberculosis and malaria could save poorer countries millions of …

News

GlaxoSmithKline-Pfizer launch HIV joint venture

November 4, 2009
Research and Development, Sales and Marketing GSK, HIV, Pfizer, ViiV

GlaxoSmithKline and Pfizer have launched a specialist HIV company with access to ten medicines developed by the two manufacturers.ViiV Healthcare, …

News

Pfizer agrees price cut in Clinton deal

September 1, 2009
Research and Development, Sales and Marketing HIV, Pfizer, price cuts

Former US President Bill Clinton has brokered major new deals with Pfizer and Mylan to cut the price of tuberculosis …

News

Pfizer agrees price cut in Clinton deal

August 7, 2009
Research and Development, Sales and Marketing HIV, Pfizer, generics

Former US President Bill Clinton has brokered major new deals with Pfizer and Mylan to cut the price of tuberculosis …

News

GSK and Pfizer to create HIV joint venture company

April 16, 2009
Research and Development, Sales and Marketing GSK, HIV, Pfizer

The world's two biggest pharma companies are to join forces to develop and market new treatments for HIV.GlaxoSmithKline is a …

News

GSK: renewing the HIV pipeline

February 16, 2009
Research and Development GSK, HIV

GlaxoSmithKline and Idenix are to co-develop IDX899 for the treatment of HIV infection. Despite having eight marketed HIV products, GSK …

News

Latest news from Datamonitor

October 13, 2008
Sales and Marketing HIV

Battle for HIV drug market share getting fiercerThe HIV market, worth $9.3 billion in 2007, is expected to grow to …

News

Atripla approved in Europe

January 3, 2008
Sales and Marketing HIV

The first ever product to combine all the drugs HIV patients need in just one daily pill has been approved …

News

Pfizer’s Celsentri approved in Europe

September 25, 2007
Research and Development, Sales and Marketing HIV

Pfizer's Celsentri has been approved in Europe, making it the first in a new, oral class of HIV drugs in …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025